Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
NK Cells +/− Atezolizumab for Lung Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial is testing the side effects and best dose of COH06, a new treatment for non-small cell lung cancer that has spread and is refractory to previous treatment. COH06 is a form of immunotherapy that uses NK cells, which are infection-fighting blood cells, from umbilical cord blood. The new gene in the COH06 NK cells makes them express PD-L1, which allows them to kill more tumor cells. IL-15 in the COH06 NK cells allows them to live longer. Atezolizumab is a monoclonal antibody that may help the body's immune
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.